As per our report, the Contraceptives Market size in North America was worth USD 7.80 billion in 2022 and estimated to reach USD 10.64 billion by the end of 2027, registering a CAGR of 6.40% during the forecast period.
Contraception methods can be permanent or temporary that are available for both men and women. Permanent methods include tubal occlusion or hysteroscopy and vasectomy. Temporary methods are of two types, i.e., hormonal and non-hormonal, in which hormonal methods include contraceptive transdermal patches, hormonal IUDs, oral contraceptive pills, vaginal implants, and vaginal rings. Non-hormonal methods include diaphragms, withdrawal methods, sponges, condoms, non-hormonal IUDs, and cervical caps. Condoms, sponges, diaphragms, and cervical caps are also referred to as barrier contraception methods.
Awareness regarding family planning and applying the one-child policy in North American nations will boost the market. Government initiative & promotion over contraceptives to control the birth rate and avoid unwanted pregnancies are estimated to support market growth. Less cost consistent and timely use of effective contraceptives in youth is projected to favor the North American contraceptive market.
Lack of knowledge over the use of the products is a significant factor hindering the market demand. Rising complication issues are also limiting the need of the market. Intake of particular contraceptives may cause breast cancer and other diseases, impeding the market demand. The availability of alternative products is also hampering the growth rate of the contraceptive market.
This research report on the North American Contraceptives Market has been segmented & sub-segmented into the following categories:
By Drug Type:
By Medical Devices:
By End User:
Geographically, North America has the highest rate of male sterilization in the world, around 11.9%. Canadian institutes & NGOs arranged counseling programs to create awareness. The U.S. contraceptives market to play the leading role in the North American market. The World Health Organization says, in developing countries, 214 million women are using contraceptive pills to avoid pregnancy in the United States. It is a significant factor for the market to grow in the United States. Increasing support from government organizations is one of the factors propelling the growth rate of the market.
The Canadian contraceptives market is leading, with prominent shares following the United States. The increasing population and growing awareness of contraceptive pills are majorly driving the demand of the market. Mexico is expected to have significant growth opportunities in the coming years with the increasing number of hospitals and pharmaceuticals.
Some of the key players that are dominating the North America contraceptives market are Bayer HealthCare AG, Teva Pharmaceutical Industries Limited, Medisafe Distribution Inc, Pace Pharmaceuticals Inc., Medicines360, Church & Dwight, Co., Inc., Actavis, Inc., CooperSurgical, Inc., Merck & Co., Inc., Reckitt Benckiser plc, Mayer Laboratories, Inc., and Pfizer, Inc.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Drug type
5.1.1 Contraceptive pills
5.1.2 Topical contraceptives
5.1.3 Contraceptive injectable
5.1.4 Others (contraceptive gels, jellies and creams)
5.2 By Medical Devices
5.2.1 Male contraceptive devices
5.2.2 Female contraceptive devices
188.8.131.52 Female condoms
184.108.40.206 Intrauterine devices
220.127.116.11 Contraceptive sponges
18.104.22.168 Contraceptive diaphragms
22.214.171.124 Contraceptive patches
126.96.36.199 Subdermal contraceptive implants
188.8.131.52 Non-surgical permanent contraceptive devices
6. Geographical Analysis
6.2 United States
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Bayer HealthCare AG
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Teva Pharmaceutical Industries Limited
8.3 Medisafe Distribution Inc
8.4 Pace Pharmaceuticals Inc
8.6 Church & Dwight, Co., Inc.
8.7 Actavis, Inc
8.9 Merck & Co., Inc
8.10 Reckitt Benckiser plc
8.11 Mayer Laboratories, Inc
8.12 Pfizer, Inc
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market outlook and Investment oppurtunities
a) List of Tables
b) List of Figures
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.